North America Remote Patient Monitoring (RPM) Market Analysis and Forecast 2025-2035
The North America Remote Patient Monitoring (RPM) market encompasses advanced medical devices, software, and services utilized to monitor patients’ health remotely, supporting timely interventions and improving outcomes. These technologies, including wearables, mobile apps, and IoT-enabled devices, enable healthcare providers to track vital signs and chronic conditions such as cardiac, diabetes, and respiratory diseases outside traditional clinical settings. Increased adoption of wireless, Bluetooth, and cloud-based solutions has spurred growth, with a focus on patient-centric and preventative care. The market is driven by an aging population, rising chronic illnesses, and a shift to value-based healthcare. Major players such as Philips Healthcare, Medtronic, and GE Healthcare are focusing on technological advancements and strategic partnerships. Barriers include regulatory challenges and high initial costs, but opportunities are expanding with rising demand for home healthcare and increased digital health literacy across the region.
Latest Market Dynamics
Key Drivers
- Rising prevalence of chronic diseases: The increasing incidence of diabetes, hypertension, and cardiovascular diseases in North America fuels demand for RPM solutions, as they enable continuous patient monitoring and proactive management. For instance, Medtronic’s latest AI-powered cardiac RPM programs launched in May 2024 facilitate timely interventions and reduce hospital readmissions.
- Adoption of advanced wearable technology: Growing consumer acceptance and availability of wearables, such as Dexcom’s G7 CGM system (released July 2024), provide real-time health data, driving RPM adoption among both healthcare professionals and patients.
Key Trends
- Integration with Electronic Health Records (EHR): Companies like Philips Healthcare, as of June 2024, now offer seamless integration of RPM solutions with major EHR platforms to improve workflow efficiency and data accessibility for clinicians.
- Expansion of telehealth partnerships: RPM providers, including GE Healthcare, are increasingly collaborating with telemedicine firms to offer comprehensive remote disease management solutions, evidenced by the company's July 2024 expansion into primary care RPM support across the US.
Key Opportunities
- Growth in home-based care: The push for reducing hospital stays and empowering patients at home fuels demand for user-friendly RPM solutions; Abbott’s newly launched home cardiac monitoring kits in June 2024 addresses this market segment.
- Increased reimbursement: Recent policy updates in the US covering more RPM services under Medicare (announced August 2024) make advanced monitoring accessible to more patients, benefiting vendors like Masimo who expanded service offerings accordingly.
Key Challenges
- Data privacy and security concerns: As RPM solutions collect sensitive patient data, compliance with evolving data protection laws is critical. Honeywell Life Sciences, in August 2024, announced enhanced security protocols to address HIPAA and regional regulations.
- Integration complexity: Successfully aligning new RPM technologies with existing hospital IT infrastructure remains a challenge for mid-to-large-scale hospital systems; Omron Healthcare’s July 2024 interoperability toolkit aims to address these barriers.
Key Restraints
- High upfront implementation costs: Small and medium-sized healthcare providers often face budget constraints in adopting comprehensive RPM solutions, limiting widespread deployment despite evident clinical benefits.
- Regulatory and compliance hurdles: Regulatory variations and approval delays across North American regions slow market entry and advanced feature rollout, as cited by ResMed’s June 2024 cross-border product delay announcement.
Market Share by Type, 2025
In 2025, the North America RPM market by type is led by devices, accounting for the highest market share due to widespread clinical adoption and ongoing innovation in smart medical equipment. Software and services also hold significant shares as healthcare providers increasingly seek integrated solutions. Wearables and mobile apps are rapidly gaining traction, driven by consumer demand for accessible and actionable health data. Market segmentation underscores a shift from traditional standalone devices to interconnected ecosystems, enabled by seamless data transfer and cloud-based analytics. The trend reflects the broader healthcare movement towards interoperability, patient engagement, and preventative care.
Market Share by Application, 2025
Cardiac monitoring dominates RPM applications in 2025, supported by high prevalence of cardiovascular conditions and advanced remote ECG and heart rhythm tracking. Diabetes management is the second largest segment, fueled by adoption of continuous glucose monitoring systems. Multi-parameter monitoring, respiratory, and blood pressure applications represent strong growth areas. The spread of RPM use across these segments highlights the versatility of remote care solutions, their impact on chronic disease management, and the growing acceptance among healthcare providers and patients for remote health monitoring as standard practice.
Market Revenue (USD Million), 2020–2035
The North America Remote Patient Monitoring market is experiencing robust revenue growth, moving from $1,600 Million in 2020 to an estimated $7,800 Million by 2035. Early pandemic-driven adoption established a new baseline for remote healthcare delivery. Continued technological advancements, coupled with expanding reimbursement frameworks and a rising elderly population, are expected to maintain momentum. The market’s upward trajectory is also fueled by a sharp rise in chronic disease prevalence and ongoing investment by leading vendors into AI, cloud, and IoT integration. Annual revenue increments reflect double-digit compound annual growth rates across the forecast period.
Year-on-Year (YOY) Market Growth (%), 2020–2035
Year-on-Year growth for the North America RPM market showcases consistent double-digit gains, peaking at 16.2% in 2025 as adoption accelerates post-pandemic. Subsequent years display slight moderation but maintain strong growth, with 10.8% in 2030 and 9.3% by 2035, reflecting ongoing expansion into new applications and user groups. Sustained investment in infrastructure, favorable policy support, and relentless innovation keep upward momentum intact. The market’s resilience through external pressures and its adaptation to emerging technologies underline its crucial role in the evolving healthcare ecosystem.
Market Share by Region, 2025
In 2025, the United States commands the largest regional share of the RPM market with 69%, owing to strong healthcare infrastructure, regulatory support, and greater investment in digital health. Canada holds 18%, benefitting from policy initiatives supporting remote care in sparsely populated areas. Mexico represents 13%, with growth driven by public-private partnerships aimed at improving healthcare accessibility. Regional distribution reflects differing funding models, digital maturity, and strategic government investments, but all demonstrate upward trends in RPM adoption as remote healthcare becomes integral across North America.
Market Share by Major Players, 2025
Philips Healthcare leads the North America RPM market with 22% share, leveraging a strong portfolio in connected health and strategic partnerships. Medtronic follows with 17%, focused on advanced cardiac and diabetes solutions. GE Healthcare (12%), Dexcom (10%), and Abbott (8%) round out the top five, each expanding into new verticals and applications. The competitive landscape is marked by innovation, mergers, service bundling, and targeted investment in AI and remote diagnostics. This ensures ongoing disruption and value creation for both providers and patients, with even smaller vendors gaining market presence through niche offerings.
Market Share by Buyers, 2025
Hospitals and health systems constitute the primary buyers in the RPM market (47%), purchasing large-scale integrated platforms for chronic disease management. Physician practices and clinics account for 26%, seeking scalable RPM tools for outpatient and chronic care. Home healthcare agencies (15%) and patients/consumers (12%) make up the remainder, with the former driving adoption of home-based solutions and the latter highlighting the growing consumerization of healthcare. Buyer distribution highlights a shift toward decentralized care models and the increased role of RPM in a diversified, patient-centric ecosystem.
Study Coverage
| Metrics | Details |
|---|
| Years | 2020-2035 |
| Base Year | 2025 |
| Market Size | 2700 |
| Regions | United States, Canada, Mexico |
| Segments | Device, Software, Services, Wearables, Mobile Apps, Cardiac Monitoring, Diabetes, Respiratory, Multi-Parameter Monitoring, Blood Pressure Monitoring, Wireless, Wired, Bluetooth, Cloud-Based, Internet of Things (IoT), Hospital Pharmacies, Retail Pharmacies, Online Channels, Direct Tenders, Distributors, Small, Medium, Large |
| Players | Philips Healthcare, Medtronic, GE Healthcare, Boston Scientific, Abbott, Masimo Corporation, Honeywell Life Sciences, Omron Healthcare, Dexcom, ResMed, Smiths Medical, iRhythm Technologies, BioTelemetry, Inc., VivaLNK, Biotronik |
Key Recent Developments
- June 2024: Medtronic introduced its AI-enabled cardiac RPM solution, enhancing predictive analytics and integration with physicians’ workflow.
- July 2024: GE Healthcare expanded its RPM-telehealth partnership network, deploying their integrated COPD and chronic care platform across new US health systems.
- June 2024: Abbott launched home-use cardiac monitoring kits, broadening direct-to-consumer channels for chronic disease management.
- August 2024: Dexcom’s G7 CGM system received Canadian regulatory clearance, providing enhanced remote glucose monitoring for diabetes patients.
- August 2024: Honeywell Life Sciences updated its RPM security infrastructure to comply with newly introduced HIPAA and Canadian data protection requirements.
